Savara Inc — Director's Dealing 2019

Jun 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Savara Inc (SVRA)
CIK: 0001160308
Period of Report: 2017-04-27

Reporting Person: RAMSAY DAVID A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-27	Common Stock	M	1142	$0.00	Acquired	23570	Direct
2019-06-17	Common Stock	P	10000	$2.39	Acquired	33570	Direct
2019-06-17	Common Stock	P	10000	$2.38	Acquired	43570	Direct
2019-06-17	Common Stock	P	5000	$2.37	Acquired	48570	Direct
2019-06-18	Common Stock	P	5000	$2.36	Acquired	53570	Direct
2019-06-18	Common Stock	P	10215	$2.35	Acquired	63785	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-27	Restricted Stock Units	$0.00	M	1142	Disposed		Common Stock (1142)	Direct

Footnotes

F1: The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017.

F3: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.